Evidence map›Paper›PMID 32131405›Full record

ReviewPolymers2020

Solvent-Free Approaches for the Processing of Scaffolds in Regenerative Medicine.

Víctor Santos-Rosales, Ana Iglesias-Mejuto, Carlos A García-González

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Stem cells and common biomaterials in dentistry: a review study.Journal of materials science. Materials in medicine · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Víctor Santos-RosalesDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, I+D Farma group (GI-1645), Faculty of Pharmacy, Health Research Institute of Santiago de Compostela (IDIS), Agrupación Estratégica de Materiales (AeMAT), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.ORCID 0000-0002-5943-1839
Ana Iglesias-MejutoDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, I+D Farma group (GI-1645), Faculty of Pharmacy, Health Research Institute of Santiago de Compostela (IDIS), Agrupación Estratégica de Materiales (AeMAT), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.
Carlos A García-GonzálezDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, I+D Farma group (GI-1645), Faculty of Pharmacy, Health Research Institute of Santiago de Compostela (IDIS), Agrupación Estratégica de Materiales (AeMAT), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.ORCID 0000-0001-9542-3679
Universidade de Santiago de Compostela · ES

Funding

Agencia Estatal de Investigación AEIConsellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia ED481A-2018/014European Cooperation in Science and Technology CA18125, AERoGELSEuropean Regional Development Fund FEDERInterreg 0245_IBEROS_1_EMinisterio de Ciencia, Innovación y Universidades RTI2018-094131-A-I00Ministerio de Economía y Competitividad RYC2014-15239Xunta de Galicia ED431C 2016/008Xunta de Galicia ED431E 2018/08Xunta de Galicia ED431F 2016/010
6 · The paper itself

Abstract

The regenerative medicine field is seeking novel strategies for the production of synthetic scaffolds that are able to promote the in vivo regeneration of a fully functional tissue. The choices of the scaffold formulation and the manufacturing method are crucial to determine the rate of success of the graft for the intended tissue regeneration process. On one hand, the incorporation of bioactive compounds such as growth factors and drugs in the scaffolds can efficiently guide and promote the spreading, differentiation, growth, and proliferation of cells as well as alleviate post-surgical complications such as foreign body responses and infections. On the other hand, the manufacturing method will determine the feasible morphological properties of the scaffolds and, in certain cases, it can compromise their biocompatibility. In the case of medicated scaffolds, the manufacturing method has also a key effect in the incorporation yield and retained activity of the loaded bioactive agents. In this work, solvent-free methods for scaffolds production, i.e., technological approaches leading to the processing of the porous material with no use of solvents, are presented as advantageous solutions for the processing of medicated scaffolds in terms of efficiency and versatility. The principles of these solvent-free technologies (melt molding, 3D printing by fused deposition modeling, sintering of solid microspheres, gas foaming, and compressed CO

Indexed as

3D printinggas foamingmelt moldingregenerative medicinescaffoldssinteringsupercritical foaming

Identifiers

PMID32131405
PMCPMC7182956
OpenAlexW3009644957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.